Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
56,251,498
-
Share change
-
+7,801,632
-
Total reported value
-
$754,888,970
-
Put/Call ratio
-
87%
-
Price per share
-
$13.42
-
Number of holders
-
113
-
Value change
-
+$105,637,327
-
Number of buys
-
75
-
Number of sells
-
60
Institutional Holders of CYMABAY THERAPEUTICS INC - COM (CBAY) as of Q2 2018
As of 30 Jun 2018,
CYMABAY THERAPEUTICS INC - COM (CBAY) was held by
113 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
56,251,498 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, BlackRock Inc., Redmile Group, LLC, PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., FMR LLC, BOXER CAPITAL, LLC, EAGLE ASSET MANAGEMENT INC, and Foresite Capital Management IV, LLC.
This page lists
113
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.